MetaCap

Kestra Medical Technologies (KMTS) vs NovoCure (NVCR)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Kestra Medical Technologies (KMTS) has outperformed NovoCure (NVCR) over the past year, gaining 8.6% versus a loss of 0.9%. NovoCure is the larger company by market cap ($1.66 billion vs $1.53 billion), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

KMTS+8.61%NVCR+3.53%
+45%+6%-33%
Oct 7, 20251 yearOct 7, 2026
KMTS+26.20%NVCR-29.53%
+38%-8%-54%
Mar 3, 20255 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

KMTS versus NVCR key metrics
MetricKMTSNVCR
Share price$25.77$14.22
Market cap$1.53B$1.66B
1-day change-2.72%-3.00%
YTD return-0.11%+9.98%
1-year return+8.61%-0.91%
5-year return—-87.33%
EPS (TTM)$-2.67$-1.30
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$30.00$21.45
52-week low$17.34$9.82
Distance from 52-week high-14.10%-33.71%
Analyst consensusstrong_buybuy
Avg. price target upside+17.54%+88.89%
Average volume357.97K1.42M
Shares outstanding59.56M116.45M
Employees4431,605
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Kestra Medical Technologies

KMTS stock →

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company.

Health Care · Medical/Dental Instruments · 443 employees

About NovoCure

NVCR stock →

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax.

Health Care · Medical/Dental Instruments · 1,605 employees

KMTS vs NVCR FAQ

Which is bigger, Kestra Medical Technologies or NovoCure?

NovoCure (NVCR) is larger, with a market capitalization of $1.66B compared with $1.53B for Kestra Medical Technologies (KMTS).

Which stock has performed better over the past year, KMTS or NVCR?

KMTS returned +8.61% over the past 12 months, compared with -0.91% for NVCR (price return, excluding dividends). Past performance does not predict future results.

Are Kestra Medical Technologies and NovoCure in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons